Lexeo Therapeutics, Inc. surges after FDA trial alignment for LX2006 in Friedreich’s ataxia. Click for more on LXEO stock ...
Contract development and manufacturing organization (CDMO) Matica Biotechnology has partnered with Calidi Biotherapeutics to advance and manufacture CLD-401, a tumor-tropic oncolytic virus designed to ...
MCO-010, an optogenetic therapy, demonstrated long-term safety and improved quality of life in patients with retinitis ...
Learn more about whether BioMarin Pharmaceutical Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on ...
TipRanks on MSN
Rocket Pharmaceuticals Reports Q3 2025 Financial Results
Rocket Pharma ( ($RCKT) ) has released its Q3 earnings. Here is a breakdown of the information Rocket Pharma presented to its investors. Rocket ...
Learn more about whether BioMarin Pharmaceutical Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ ...
Third quarter revenues up 6% driven by EXPAREL volume growth of 9% -- -- Several key milestones advance 5x30 path to growth ...
According to Nova One Advisor, the global viral vector & plasmid DNA manufacturing size is calculated at USD 7.54 billion in 2025 and is expected to surpass around USD 27.71 billion by 2034, growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback